RSCM
INSY

Rock Springs Capital Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Rock Springs Capital Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-100,000
Closed -$1.18M – 141
2016
Q3 		$1.18M Sell
100,000
-265,500
-73% -$4.04M 0.07% 131
2016
Q2 		$4.73M Hold
365,500
– – 0.35% 84
2016
Q1 		$5.84M Buy
365,500
+27,000
+8% +$513K 0.49% 70
2015
Q4 		$9.69M Buy
338,500
+30,500
+10% +$845K 0.73% 45
2015
Q3 		$8.77M Buy
308,000
+161,000
+110% +$5.93M 0.71% 50
2015
Q2 		$5.28M Buy
+147,000
New +$4.58M 0.39% 84

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rock Springs Capital Management's INSY Position: Q4 2016 in Review

Rock Springs Capital Management sold out of Insys Therapeutics, Inc. (INSY) in Q4 2016, closing a stake of 100,000 shares — an estimated $1.18M sold.

Rock Springs Capital Management first reported a position in INSY in Q2 2015 and held it in 6 quarters. The position peaked at $9.69M in Q4 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • Rock Springs Capital Management reported no remaining Insys Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Rock Springs Capital Management sold 100,000 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $1.18M.
  • Rock Springs Capital Management first reported a position in Insys Therapeutics, Inc. in Q2 2015 and held it in 6 quarters.
  • Rock Springs Capital Management's Insys Therapeutics, Inc. position peaked at $9.69M in Q4 2015.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on Rock Springs Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.